Japan Medical
Tokyo, Japan International Patient Support
Contact Us
Japan Health Check PlanningEvidence Reviewed 11 Aug 2026

PET-CT vs. MRI for Cancer Screening

PET/CT and MRI don’t answer the same question, and for someone who feels fine, neither takes the place of proven organ-specific screening. When you do have symptoms, an abnormal result, or a cancer diagnosis, the next scan should be picked around that specific clinical question — not the other way around.

Start with why you’re testing. A whole-body scan can look reassuring while still missing cancers that mammography, stool testing, endoscopy, cervical testing or other targeted methods pick up more reliably.
Option comparisonAppointment coordinationCommunication support
Medical imaging used when comparing PET-CT and MRI for cancer-related health checks
Short Answer

For average-risk adults with no symptoms, PET/CT and whole-body MRI are not substitutes for evidence-based cancer screening. PET/CT is mainly an oncology tool for selected cancers; MRI is strongest when detailed soft-tissue imaging is needed. A normal result from either test does not rule out every cancer.

Use the scan to answer a defined question, not as a universal cancer check.

Start With Your Situation

The same scan means different things in different situations

01Situation

Screening and diagnosis aren’t the same thing — and they shouldn’t be handled that way.

01
No symptoms, average risk

Begin with proven age- and risk-based screening. Japan’s National Cancer Center does not recommend PET as a replacement for the five population screening programs with established evidence of reducing cancer deaths.

02
Symptoms or an abnormal result

This is a diagnostic problem, not routine screening. The useful next test depends on the organ, symptom and previous finding. Targeted CT, MRI, ultrasound, endoscopy, laboratory testing or biopsy may be more appropriate than a whole-body scan.

03
Already diagnosed with cancer

PET/CT or MRI may be used for staging, treatment planning, response assessment or suspected recurrence depending on the cancer type. At this point, imaging should follow an oncology plan rather than a general checkup package.

04
Previous cancer or treatment history

The original cancer type, pathology, stage, treatment dates and earlier imaging usually matter more than choosing a scan by name.

PET-CT and MRI imaging comparison for cancer-related evaluation
PET-CT vs. MRI

What each test can and cannot answer

02Compare
Decision point
PET/CT
MRI
Main information

FDG uptake plus CT anatomy.

High-detail tissue anatomy; some protocols add diffusion or contrast.

Average-risk screening

Not an evidence-based replacement for established population screening.

ACR says evidence is insufficient for total-body MRI in asymptomatic people without relevant risk factors.

Radiation

Yes. Radiation comes from both the radioactive tracer and CT.

No ionizing radiation.

Known cancer

Often used for staging, response or recurrence when the cancer and tracer are suitable.

Often used for local detail in the brain, liver, pelvis, prostate and other soft tissues.

False findings

Inflammation and other benign processes can take up FDG; small or low-uptake tumors may be missed.

Non-specific incidental findings can lead to further imaging or procedures.

Can it prove cancer?

No. Suspicious uptake may still need tissue sampling or another targeted test.

No. Suspicious imaging findings may still need biopsy or other confirmation.

What the Numbers Say

Numbers that change how the result should be interpreted

03Evidence

PET/CT dose and preparation change from one protocol to the next. These numbers come from published references — they’re not a single fixed dose or a promise that every facility works the same way.

22.7 mSvApproximate adult whole-body PET/CT effective dose listed by RadiologyInfo. Actual dose can vary substantially.
0 mSvMRI uses no ionizing radiation. Implant, metal, heating and possible contrast risks still need review.
4–6 hSNMMI/EANM guidance uses a 4–6 hour fasting period before FDG injection; follow the facility’s exact instruction.
PET componentThe IAEA gives a typical adult FDG-PET effective dose of about 8 mSv when 400 MBq is administered.Source: International Atomic Energy Agency
CT componentIAEA examples range from about 7 mSv for low-dose whole-body localization CT to as high as 30 mSv for high-resolution diagnostic whole-body CT.Source: IAEA; values illustrate protocol variation
Small lesionsNippon Medical School Chiba Hokusoh Hospital notes that cancers under 1 cm become harder for FDG PET to detect as size decreases.Japanese hospital guide; not a universal size cutoff
Typical visitThe same hospital describes about 1 hour of uptake time, about 25 minutes of scanning and roughly 3 hours from check-in to completion.Facility workflow example; times vary by center
GlucoseThat hospital warns image clarity may be difficult when fasting blood glucose exceeds 200 mg/dL. Diabetes instructions should be confirmed before the appointment.Facility-specific operational threshold

Radiation dose estimates exposure — it doesn’t directly predict your personal cancer risk. Protocol, body size and CT settings all play a role.

Already have a package quote but you’re not sure what it covers?

Send the included tests and scan protocol — we can help you compare the scope before you book.

Organ-Specific Screening

Start with the test proven for that organ

04Screening

Japan’s National Cancer Center points to five population screening programs backed by established evidence. PET, CT and tumor markers may matter after a finding or diagnosis — but they’re not meant to take the place of these programs.

StomachAge 50+, every 2 yearsUpper GI X-ray or upper GI endoscopy. PET/CT or MRI does not replace this screening route.
ColorectalAge 40+, every yearImmunochemical fecal occult blood testing. A positive result needs diagnostic follow-up; a whole-body scan is not a substitute.
LungAge 40+, every yearJapan’s national program uses interview plus chest X-ray. Risk-specific lung evaluation may follow a different pathway.
BreastAge 40+, every 2 yearsMammography. NCI notes breast MRI may be added for some people at high risk, not used as a blanket replacement.
CervicalAge 20+, every 2 yearsCytology-based screening. For eligible municipal programs, HPV testing alone may be used from age 30 at 5-year intervals.

Source: National Cancer Center Japan cancer screening guidance.

A normal PET/CT or MRI won’t reset these schedules.

Screening tests can have false-negative results, so stick with the age- and risk-based schedule that applies to you unless a qualified clinician tells you otherwise.

Cancer screening imaging reviewed together with organ-specific screening tests
Before You Book

Details that can change the scan or the preparation

05Preparation

Send these details early — they can shift whether PET/CT, MRI, another test or a different prep plan makes more sense.

Previous findingsImaging reports, pathology, endoscopy, blood tests and the organ that needs follow-up.
Current symptomsPersistent bleeding, cough, pain, bowel changes, breast changes or other new symptoms should not be handled as routine screening.
Diabetes and glucose controlFDG PET usually requires fasting. High glucose and recent insulin can change tracer distribution, so medication instructions must be confirmed with the imaging center.
Pregnancy or breastfeedingPET/CT uses ionizing radiation and a radioactive tracer, so this must be disclosed before scheduling.
Implants and devicesPacemakers, ICDs, aneurysm clips, pumps, monitors and metal fragments need MRI compatibility review.
Kidney function and contrast historyIf contrast-enhanced MRI is being considered, kidney function and previous contrast reactions may affect the plan.
Claustrophobia or limited mobilityBoth scans require lying still. Severe claustrophobia or difficulty transferring may change facility suitability.
Recent procedures or inflammationVaccination, surgery, biopsy, bronchoscopy and active inflammation can affect FDG uptake. Send the dates so the imaging team can decide whether timing matters.
Prior cancer historyCancer type, pathology, stage, treatment dates and previous imaging are more useful than choosing a scan by name.

Not sure which records to pull together before asking for a quote?

Start with your age, main concern, previous test results and preferred dates in Japan.

What You Might Pay in Japan

Compare the scope before comparing the price

06Costs

A PET/CT scan isn’t the same product as a head MRI, and neither is the same as a whole-body MRI protocol or a full health-check package. A low headline price may leave out specialist review, contrast, extra imaging or international support — so compare the scope before you compare the number.

Japan health screening package comparison and cost planning
About ¥100,000Fujimoto General Hospital currently lists self-pay PET/CT at approximately ¥100,000 before tax. This is a scan price example, not a universal Japan rate.
¥145,200Nihonbashi Muromachi Mitsui Tower Midtown Clinic lists a resident comprehensive screening course with head MRI/MRA at ¥145,200 including tax; the published exam time is about 4 to 5.5 hours. Foreign-visitor pricing is different.
International pricingForeign-visitor fees can differ from resident rates. Translation, coordination, specialist explanations and additional tests may be quoted separately.
What to compareImaging range, tracer or contrast, radiology interpretation, same-day explanation, additional tests, report language, translation and follow-up arrangements.

Public price examples checked 11 August 2026. Sources: Fujimoto General Hospital and Nihonbashi Muromachi Mitsui Tower Midtown Clinic. Prices and visitor fees may change.

Follow-up imaging review after a health check finding
Once You Get a Result

A scan finding is not the same as a cancer diagnosis

07Follow-up
No suspicious finding

Continue the screening schedule that matches your age and risk. One negative whole-body scan cannot guarantee that every cancer is absent.

Uncertain finding

Ask which organ is involved, how concerning the finding is and which targeted follow-up test is recommended.

Suspicious finding

Ask what needs confirmation. Depending on the organ, the next step may be targeted CT or MRI, ultrasound, endoscopy or biopsy. A Japanese PET/CT patient guide notes biopsy is often required for a definitive cancer diagnosis.

Confirmed cancer

Staging and treatment planning become cancer-specific. PET/CT or MRI may then be selected according to tumor type, stage and the question that needs to be answered.

What the scan cannot tell you

A PET/CT or MRI result alone cannot give a reliable survival estimate. Prognosis depends on the confirmed cancer type, stage, tumor biology, treatment options and overall health.

How We Help

Japan health-check planning and coordination

08Support

We help international visitors pull together their medical information, understand what a proposed check actually includes, and coordinate the practical steps in Japan. We aren’t a hospital or clinic.

Medical suitability, diagnosis and treatment decisions remain with qualified medical professionals.

Health check planning support for international visitors in Japan
01
You send the situation

Age, main concern, symptoms, family history, previous reports, cancer history if relevant and preferred dates.

02
We organize the questions

We separate routine screening from diagnostic follow-up and identify what needs clarification.

03
We compare the scope

We check the included tests, preparation, exclusions and possible extra fees.

04
We coordinate the practical steps

We coordinate appointment communication, documents, timing and language support.

05
You arrive with a clearer plan

You know what is booked, what to bring, how to prepare and what needs follow-up.

FAQ

Questions patients usually need answered first

10Questions

The right answer changes with symptoms, age, smoking history, family history, previous cancer and earlier test results.

Patient health check questions reviewed before PET-CT or MRI planning
Which is better for cancer screening, PET-CT or MRI?

Neither is universally better. For average-risk adults without symptoms, proven organ-specific screening should come first. PET/CT is mainly used for selected oncology questions; MRI is chosen when detailed soft-tissue imaging is needed.

Can PET-CT detect every cancer?

No. Small or low-FDG-uptake tumors can be difficult to detect, while inflammation can also look active. A Japanese hospital guide notes that lesions below 1 cm become harder to detect as size decreases.

Does a normal whole-body MRI rule out cancer?

No. ACR does not recommend total-body MRI as routine screening for asymptomatic people without relevant risk factors, and MRI does not replace established organ-specific tests.

How much radiation is in PET-CT?

There is no fixed dose. RadiologyInfo lists about 22.7 mSv for a typical adult whole-body protocol. IAEA gives about 8 mSv for the PET component, while CT dose changes with the CT protocol.

Should I do PET-CT and MRI together for maximum coverage?

Not automatically. More imaging can produce non-specific findings, extra follow-up and higher cost. The useful combination depends on the organ and clinical question.

What if I already have symptoms or an abnormal result?

That is a diagnostic question, not routine screening. The next test should target the symptom or abnormal organ rather than simply adding a whole-body scan.

What should I send before asking for a quote?

Send your age, main concern, symptoms, family history, previous reports, cancer history if relevant, diabetes status, implants or devices and preferred dates in Japan.

Plan Before You Book

Tell us what you want to check and what you already know

Send your age, main concern, previous results and preferred dates in Japan. We’ll help you organize the next questions and compare the practical options before you commit to a package.

WhatsApp: +81-8070161366LINE: +81-8075357788

Educational and coordination information only. We aren’t a hospital or clinic and don’t provide diagnosis or treatment. If you have persistent or concerning symptoms, seek diagnostic medical evaluation rather than waiting for routine screening.